Page 141 - Merck Sharp News Today

Hetero-Merck alliance seeks emergency use nod for anti-COVID drug Molnupiravir in India Under this licensing deal, Hetero will be allowed to sell Molnupiravir in India and in other low-and middle-income countries (LMICs), following the approvals for emergency use authorisation by local regulatory agencies Joe C Mathew | April 27, 2021 | Updated 21:48 IST Molnupiravir will be manufactured in Heteros USFDA and EU approved formulation facility in Hyderabad Hyderabad-based Hetero has entered into ...

Search jobs 27-Apr-2021 Glucocorticoid Agonist Market Size Key Opportunity, Application And Forecast To 2028 By Major industry Players: GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Vintage Labs., Jubilant Cadista Data Bridge Market Research announces the addition of new research analysis to the wide international database Glucocorticoid Agonist Market to offer insightful views over the forecast period of 2020 – 2027. Th...

Merck Pharma gives voluntary licences to five Indian companies on molnupiravir April 27, 2021 Molnupiravir is being studied in a Phase 3 trial for treatment of non-hospitalised Covid patients MSD Pharmaceuticals has announced non-exclusive voluntary licensing agreements on its investigational oral drug molnupiravir, with five Indian generic manufacturers. The licensees are Cipla, Dr Reddy’s Laboratories Limited, Emcure Pharmaceuticals, Hetero Labs and Sun Pharma, who have World Health Organi...

Share this article Share this article DUBLIN, April 27, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the initiation of ARTISTRY-6, a global phase 2 trial evaluating the anti-tumor activity, safety and tolerability of nemvaleukin alfa (nemvaleukin) monotherapy in patients with melanoma who have been previously treated with anti-PD-(L)1 therapy. The study will evaluate intravenously administered (IV) nemvaleukin in patients with mucosal melanoma and subcutaneously administere...

Share The University of Sydney has awarded an honorary doctorate to David Anstice AO in recognition of his outstanding contribution to business, education and the wider community. With more than 45 years’ experience in the global pharmaceutical industry, Mr Anstice has been instrumental in improving relations between Australia and the United States. Vice-Chancellor and Principal of the University of Sydney Professor Stephen Garton conferred the Doctor of Business (honoris causa) on Mr Anstice...

Search jobs 22-Apr-2021 Bronchiectasis Market 2021 Global Market Size, Share, Regional Growth Analysis, Upcoming Trends, R&D Status, Technology Source and Development Analysis with Current and Future Industry Figures Research Report 2028 The market study on Bronchiectasis Marketpublished by Data Bridge Market Research exhibits the important aspects that are estimated to shape the growth of the global Bronchiectasis market over the forecast period. B...

Search jobs 22-Apr-2021 Ischemic Heart Disease Market Size 2021 Trending News, Industry Growth, Share, Ecosystem Player Profiles, Progression Status and Business Trends To 2028 Data Bridge Market Research has added a new report titled Global Ischemic Heart Disease Market Size, Share, Growth, Industry Trends and Forecast to 2028 in its database, which describes a systematic image of the market and provides an in-depth explanation of the various facto...

 E-Mail IMAGE: Senior investigator Samuel Klein, MD, (left), in the laboratory with Adewole Okunade, PhD. Kleins team found that NMN improved the ability of insulin to increase glucose uptake in skeletal muscle.... view more  Credit: Matt Miller A natural compound previously demonstrated to counteract aspects of aging and improve metabolic health in mice has clinically relevant effects in people, according to new research at Washington University School of Medicine in St. Louis. A sma...

Physiological differences between the sexes mean woman are nine times more likely to die from a broken heart than men, scientists claim. New research by Monash University in Melbourne for the first time uncovered a way to prevent and reverse damage caused by broken-heart syndrome, also known as Takotsubo cardiomyopathy. The syndrome causes a weakening of the left ventricle, the hearts main pumping chamber and is brought on by stressful emotional triggers often following traumatic events - such...

St. Charles Borromeo Seminary to move to Gwynedd-Mercy University For almost 190 years, St. Charles Borromeo Seminary has educated thousands of Catholic priests for service in the Archdiocese of Philadelphia and other dioceses.  On Monday, the archdiocese announced the seminary would be moving from its long-time home at City and Lancaster avenues in the Overbrook section of Lower Merion to 15 acres of land and two buildings that it would purchase from Gwynedd-Mercy University in Lower Gwyned...